Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice
- PMID: 8493802
Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice
Abstract
To evaluate the prevalence of latent PSE in unselected ambulatory patients with liver cirrhosis practicing physicians were asked to perform two non instrumental psychometric tests (number connection test and line tracing test) on patients with clinical signs of liver cirrhosis and portal hypertension. Tests were repeated after 8 weeks of treatment with Lactulose in those patients considered to have latent PSE at the initial evaluation. 296 physicians tested a total of 783 patients, 771 of these could be evaluated. 551 patients (71.5%) were considered to have latent PSE. There was a significant correlation between psychometric test results and biochemical parameters related to liver function. Repeat testing after 8 weeks treatment with Lactulose revealed definite improvement of psychometric test results in 88% of the patients. At the final evaluation only about 30% of the patients fulfilled the criteria of latent PSE. There was a statistically significant albeit weak correlation between changes in biochemical parameters and psychometric improvement. Psychometric testing with simple non instrumental tests proved to be practicable in the office setting.
Similar articles
-
[Diagnosis and prevalence of latent hepatic encephalopathy].Z Gastroenterol. 1990 Nov;28(11):610-5. Z Gastroenterol. 1990. PMID: 2288139 German.
-
Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.Am J Gastroenterol. 1999 Aug;94(8):2214-8. doi: 10.1111/j.1572-0241.1999.01295.x. Am J Gastroenterol. 1999. PMID: 10445552
-
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.Hepatology. 1997 Dec;26(6):1410-4. doi: 10.1053/jhep.1997.v26.pm0009397979. Hepatology. 1997. PMID: 9397979 Clinical Trial.
-
[Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient].Fortschr Med. 1996 Apr 30;114(12):141-6. Fortschr Med. 1996. PMID: 8682429 Review. German.
-
Minimal hepatic encephalopathy.J Assoc Physicians India. 2009 Nov;57:760-3. J Assoc Physicians India. 2009. PMID: 20329443 Review.
Cited by
-
Selective impairments of resting-state networks in minimal hepatic encephalopathy.PLoS One. 2012;7(5):e37400. doi: 10.1371/journal.pone.0037400. Epub 2012 May 25. PLoS One. 2012. PMID: 22662152 Free PMC article.
-
Neuropsychological aspects of portal-systemic encephalopathy.Metab Brain Dis. 1998 Dec;13(4):361-77. doi: 10.1023/a:1020645110880. Metab Brain Dis. 1998. PMID: 10206827
-
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.Cochrane Database Syst Rev. 2016 May 6;2016(5):CD003044. doi: 10.1002/14651858.CD003044.pub4. Cochrane Database Syst Rev. 2016. PMID: 27153247 Free PMC article.
-
Role of local and distant functional connectivity density in the development of minimal hepatic encephalopathy.Sci Rep. 2015 Sep 2;5:13720. doi: 10.1038/srep13720. Sci Rep. 2015. PMID: 26329994 Free PMC article.
-
Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil.Metab Brain Dis. 2001 Jun;16(1-2):43-53. doi: 10.1023/a:1011662411913. Metab Brain Dis. 2001. PMID: 11726088 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical